Brain Fog After COVID: Causes, Duration, and Treatment

Brain fog after COVID is a lasting problem with memory, attention and word finding that affects about 22% of people 12 or more weeks after infection, according to a 2022 meta-analysis of 43 studies by Ceban and colleagues, and it is linked to neuroinflammation, blood-brain barrier leakage and micro-clotting. Most people improve within 3 to 12 months, a smaller group still struggles after a year, and treatment targets the drivers: sleep, pacing, mast cell activation and inflammation.

At a Glance

---

You recovered from COVID: the fever broke, the cough cleared, the test turned negative. But weeks or months later, you can’t think straight. You walk into rooms and forget why. You search for words mid-sentence. You read the same paragraph four times. Colleagues notice you’re slower. You wonder if something is seriously wrong with your brain.

This is post-COVID brain fog, and it’s one of the most common and distressing symptoms of Long COVID. Clinicians may record it as post-COVID-19 condition (the World Health Organization term), post-acute sequelae of SARS-CoV-2 infection (PASC), or cognitive long COVID. The good news: researchers now understand much more about why it happens, and clinicians have a clearer picture of which treatments are worth trying and which have failed in trials.

What Does Post-COVID Brain Fog Feel Like?

Post-COVID brain fog feels like thinking through cotton wool: slower processing, a shorter attention span and a memory that drops things it used to hold easily. It is a patient term, not a formal diagnosis, for cognitive symptoms that start or worsen after SARS-CoV-2 infection.

The symptoms people describe most often are:

• Trouble finding words, or swapping one word for another mid-sentence.
• Short-term memory lapses, such as forgetting why you entered a room or what you just read.
• Slower thinking and reaction time, especially under time pressure.
• Difficulty concentrating, multitasking or following a conversation in a noisy room.
• Mental fatigue that sets in after reading, screen work or meetings, sometimes with a delayed crash a day later.

Who is most likely to get brain fog after COVID?

Brain fog can follow mild infections, but severe illness raises the risk. In the REACT study of 112,964 adults in England, Hampshire and colleagues (NEJM, 2024) found larger measured cognitive deficits in people who had been hospitalized or admitted to intensive care, and in people infected during the original and Alpha waves than in those infected with later variants. Brain fog also overlaps heavily with post-COVID fatigue, sleep disruption and dysautonomia.

Why COVID Causes Brain Fog: The Mechanisms

COVID-related brain fog isn’t “just anxiety” or deconditioning. Research has identified several concrete biological mechanisms that help explain why SARS-CoV-2 disrupts cognitive function, sometimes long after the acute infection has cleared.

Neuroinflammation and Microglial Activation

Microglia are the brain’s resident immune cells. During and after COVID, these cells can become chronically activated, a state called “microglial priming.” Instead of returning to their resting state, they continue pumping out inflammatory cytokines (TNF-alpha, IL-6, IL-1beta) that disrupt normal neuronal communication. Small PET imaging studies have reported elevated neuroinflammatory markers in Long COVID patients with cognitive complaints, even when standard MRI appears normal.

Think of it this way: the brain’s immune system turned on during infection and never fully turned off. The result is a low-grade inflammatory state that impairs processing speed, working memory, and attention. A Stanford-led study, Fernández-Castañeda et al. (Cell, 2022), showed that even mild respiratory COVID in mice triggered lasting microglial reactivity and loss of myelin-forming cells, a pattern that resembles “chemo brain.”

Blood-Brain Barrier Disruption

The blood-brain barrier (BBB) is a highly selective membrane that protects the brain from circulating inflammatory molecules, pathogens, and toxins. COVID can damage this barrier through direct endothelial infection and inflammation. Once “leaky,” the BBB allows peripheral inflammatory mediators to enter the brain, amplifying neuroinflammation.

Researchers at Trinity College Dublin used dynamic contrast-enhanced MRI to detect BBB leakage in Long COVID patients with brain fog, and they found signs of sustained systemic inflammation and coagulation changes in the same group, according to Greene et al. in Nature Neuroscience (2024).

Micro-Clotting

One of the most discussed findings in Long COVID research is the presence of micro-clots: tiny fibrin clots that resist the body’s normal clot-dissolving mechanisms. Pretorius and colleagues (Cardiovascular Diabetology, 2021) found persistent clotting protein pathology and raised antiplasmin in Long COVID blood samples. These micro-clots may block capillaries throughout the body, including in the brain, reducing oxygen delivery to neurons. Some researchers believe micro-clotting is a central driver of brain fog, fatigue and exercise intolerance, although no anticoagulant regimen has yet been supported by a controlled trial for this use.

Autoimmune Mimicry

COVID triggers the production of autoantibodies in a meaningful share of patients. Some of these autoantibodies may target neuronal proteins, so the immune system begins reacting against the brain’s own cells. This mechanism mirrors what neurologists see in established autoimmune neurological conditions and may explain why a few Long COVID patients develop symptoms resembling autoimmune encephalitis. The evidence here is still early and comes mostly from laboratory and small clinical studies.

Viral Persistence in the CNS

There’s growing evidence that SARS-CoV-2 or viral fragments can persist in the body long after the acute infection, in the gut, lymph nodes, and possibly the brain. This persistent viral reservoir may continuously stimulate the immune system, maintaining the inflammatory state that drives brain fog. In an NIH autopsy study, Stein et al. (Nature, 2022) detected SARS-CoV-2 RNA throughout the brain as late as 230 days after symptom onset in one case.

Changes in Brain Structure

Brain imaging before and after infection adds a further clue. Using UK Biobank scans, Douaud et al. (Nature, 2022) found that people who had COVID showed a greater loss of grey matter thickness in smell-related and limbic regions and a greater decline in cognitive test performance than matched controls. Whether these changes reverse is still being studied.

How Long Does Post-COVID Brain Fog Last?

Post-COVID brain fog usually lasts weeks to months, and most people improve within 3 to 12 months, although a smaller group still has symptoms after one to two years. The honest answer is that it varies, but the overall direction for most people is improvement.

3 to 6 months: Many patients with post-COVID brain fog see meaningful improvement within this window, especially with supportive measures like sleep optimization, anti-inflammatory nutrition, and a paced return to cognitive activity.

6 to 12 months: A significant cohort continues to improve gradually through this period. Research suggests that neuroinflammation slowly resolves over time as the immune system recalibrates.

12 to 24 months and beyond: A smaller but real subset of patients continues to experience persistent cognitive difficulties beyond a year. These patients often have identifiable complicating factors, such as mast cell activation, persistent autoimmunity, sleep disorders, or untreated hormonal imbalances, that need targeted treatment.

Objective testing supports this picture. In Hampshire et al. (NEJM, 2024), people whose persistent symptoms had resolved scored similarly to people who had short illnesses, while those with unresolved symptoms showed the largest deficits, mainly in memory, reasoning and executive function. The authors note that the long-term course of these deficits is still uncertain.

The trajectory is not a straight line. Relapses are common, often triggered by physical or emotional stress, illness, or overexertion. But the overall trend for most patients is improvement.

Diagnostic Workup: What to Test For

A thorough diagnostic workup serves two purposes: ruling out other treatable causes of cognitive dysfunction and identifying specific Long COVID mechanisms that can be targeted with treatment. No single blood test or scan confirms post-COVID brain fog, so the diagnosis rests on history, timing and excluding other causes.

Inflammatory markers: CRP, ESR, ferritin, IL-6 (if available). These are often mildly elevated in Long COVID but can also be normal, which does not rule out neuroinflammation.

Autoimmune panels: ANA, thyroid antibodies, and, if available, neuronal autoantibody panels. Post-COVID autoimmunity is increasingly recognized.

Brain MRI: Typically normal in Long COVID brain fog, but important to rule out structural lesions, demyelination, or other pathology. Functional MRI and PET scans may show abnormalities but are primarily research tools at this point.

Neuropsychological testing: Formal neuropsych testing can quantify and characterize the cognitive deficits, and processing speed and executive function are the domains most commonly affected. This testing is also valuable for documenting disability when needed.

Additional testing: Thyroid function, B12, folate, vitamin D, iron studies, cortisol, and sleep studies should be checked to exclude overlapping or contributing conditions. An active stand test or tilt table test can check for postural orthostatic tachycardia syndrome (POTS), which often travels with brain fog.

Which doctors evaluate post-COVID brain fog?

A primary care physician is usually the first stop and can order the core blood work. Depending on the findings, the next referral may be a neurologist, a neuropsychologist for formal cognitive testing, a sleep medicine specialist, a cardiologist or autonomic specialist for suspected POTS, or an allergist and immunologist for suspected mast cell activation. Many academic medical centers run dedicated post-COVID or Long COVID clinics staffed by physical medicine and rehabilitation physicians, and the UK’s NICE guideline NG188 on managing the long-term effects of COVID-19 recommends this kind of coordinated, multidisciplinary assessment.

Treatment Approaches for Post-COVID Brain Fog

Treatment for post-COVID brain fog works best when it’s layered: foundational lifestyle changes first, then targeted interventions matched to the individual’s specific presentation. No medication is FDA approved for Long COVID brain fog, so the drugs below are used off label, and most of the evidence comes from small or uncontrolled studies. A wider overview of the options sits in our Long COVID treatment guide.

Foundational Approaches

Sleep optimization is arguably the single most impactful intervention. Poor sleep amplifies neuroinflammation and impairs the glymphatic system, the brain’s waste clearance mechanism that operates primarily during deep sleep. Prioritize sleep hygiene, treat any underlying sleep disorders such as sleep apnea or insomnia, and aim for 7 to 9 hours nightly.

Anti-inflammatory diet: A Mediterranean-style diet rich in omega-3 fatty acids, polyphenols, and fiber has the strongest evidence base for reducing systemic inflammation in general, though it has not been tested specifically for post-COVID brain fog. Limit ultra-processed foods and excess sugar. Some patients benefit from an elimination diet, ideally supervised by a dietitian, to identify individual food triggers.

Paced, symptom-led activity: Carefully titrated physical activity improves cerebral blood flow and promotes BDNF (brain-derived neurotrophic factor) release, which supports neuronal repair. The key is pacing: pushing too hard can trigger post-exertional malaise (PEM) in Long COVID patients. NICE’s 2021 ME/CFS guideline (NG206) advises against fixed, incremental graded exercise therapy for people with ME/CFS, and many Long COVID clinics apply the same caution when PEM is present. Start with gentle walking and increase only as your symptoms allow, and apply the same pacing to mentally demanding work.

Pharmacological Options

Low-dose naltrexone (LDN): Typically dosed at 1.5 to 4.5 mg at bedtime, LDN is thought to modulate neuroinflammation by temporarily blocking opioid receptors, leading to an upregulation of endorphins and a reduction in microglial activation. Naltrexone is FDA approved at a standard 50 mg dose for opioid and alcohol use disorders, so low-dose use for Long COVID is off label and usually compounded. In an Irish pre-post study of 52 patients, O’Kelly et al. (Brain, Behavior, and Immunity: Health, 2022) reported improvement in several Long COVID symptom measures after two months of LDN, but the study had no placebo group. It’s generally well tolerated and inexpensive; see our overview of low-dose naltrexone for dosing.

NAD+ IV therapy: Nicotinamide adenine dinucleotide is a critical coenzyme for cellular energy production and DNA repair. IV NAD+ infusions aim to restore depleted cellular energy reserves. Rigorous RCT data are lacking, and the support for improvement in fatigue and cognitive function in a subset of patients comes from clinical experience and preliminary studies. Infusions are cash pay at most clinics, and clinics offering NAD+ infusions vary in how they screen patients.

Antihistamines (if MCAS component): H1 and H2 blockers (cetirizine + famotidine) can improve brain fog in patients with mast cell activation. In a UK observational study of 65 people who had mild COVID, Glynne et al. (Journal of Investigative Medicine, 2022) reported that 72% of the Long COVID patients who took histamine receptor antagonists described clinical improvement, though there was no placebo group. This is an underappreciated treatment pathway; see the MCAS section below.

Supplements with Evidence

Omega-3 fatty acids (EPA/DHA) are anti-inflammatory and neuroprotective; a common target is 2 to 3 g combined EPA/DHA daily. Lion’s mane mushroom promotes nerve growth factor (NGF) production in laboratory studies, with emerging but limited evidence for cognitive benefit. Alpha lipoic acid is an antioxidant with neuroprotective properties; 600 mg daily is a common dose. None of these has been tested in a controlled trial for post-COVID brain fog, and supplements can interact with prescription drugs, so check with a pharmacist or physician first. Our roundup of brain fog supplements covers the wider evidence.

Emerging Therapies

Hyperbaric oxygen therapy (HBOT): A randomized, sham-controlled, double-blind trial from Israel, Zilberman-Itskovich et al. (Scientific Reports, 2022), randomized 73 Long COVID patients to 40 daily sessions of HBOT or sham and found significant improvement in global cognitive function, attention and executive function, along with energy, sleep and psychiatric symptoms. A follow-up by Hadanny et al. (Scientific Reports, 2024) reported that the gains persisted more than a year after the last session. The proposed mechanism includes enhanced oxygen delivery, reduction of neuroinflammation, and promotion of neuroplasticity.

The trial was small, several authors disclosed financial ties to a commercial HBOT company, and Long COVID is not among the indications the Undersea and Hyperbaric Medical Society recognizes, so insurers rarely pay. Access and cost remain barriers. The clinical data on HBOT for Long COVID are reviewed in more detail separately, and the national list of hyperbaric oxygen clinics shows which providers offer medical-grade chambers.

Stellate ganglion block (SGB): An injection of local anesthetic into the stellate ganglion (a nerve bundle in the neck), usually performed by an anesthesiologist or pain specialist under ultrasound guidance, that is thought to “reset” the sympathetic nervous system. Originally used for PTSD, case series have reported improvement in Long COVID brain fog, fatigue, and dysautonomia. Research is ongoing.

What has not worked in trials?

Computerized brain training and brain stimulation have not outperformed control activities so far. The NIH-funded RECOVER-NEURO trial (NCT05965739) randomized 328 adults with cognitive Long COVID at 22 US sites to online cognitive training, a structured cognitive rehabilitation program, or transcranial direct current stimulation (tDCS), and found no benefit over the comparison arms after 10 weeks, according to Knopman et al. in JAMA Neurology (2026). All five groups improved somewhat over time, a reminder that many people recover gradually and that controlled trials matter.

Treatment Approaches: Evidence and Timeline

The table below compares the main treatments for post-COVID brain fog by strength of evidence, typical time to any improvement and approximate cost. Evidence levels describe research specific to Long COVID or brain fog where it exists; costs are rough US cash prices, and most of the clinic-based options are not covered by insurance for this use.

Treatment	Evidence Level	Typical Timeline to Improvement	Approximate Cost
Sleep optimization	Strong for cognition in general	2 to 4 weeks	Free / low
Anti-inflammatory diet	Limited (general inflammation data, observational)	4 to 8 weeks	Variable
Paced activity (not graded exercise therapy)	Guideline-supported when PEM is present (NICE)	4 to 12 weeks	Free
Omega-3 fatty acids	Limited (not tested for post-COVID brain fog)	4 to 8 weeks	$20-40/month
Low-dose naltrexone	Low (uncontrolled pre-post studies, growing)	4 to 12 weeks	$30-50/month
Antihistamines (H1/H2)	Low (observational, if MCAS present)	1 to 4 weeks	$10-30/month
NAD+ IV therapy	Preliminary (clinical experience)	1 to 4 sessions	$250-1,000/session
Lion’s mane	Preliminary (laboratory and small human studies)	4 to 8 weeks	$20-40/month
Alpha lipoic acid	Limited (neuroprotection data)	4 to 12 weeks	$15-30/month
HBOT	Moderate (one small sham-controlled RCT with follow-up)	20 to 40 sessions	$150-300/session
Stellate ganglion block	Preliminary (case series)	Days to weeks	$500-2,000/procedure

Computerized cognitive training and tDCS are left out of the table because the RECOVER-NEURO trial found no benefit over control activities. Confirm the total cost of a full course before starting any clinic-based treatment.

The MCAS Connection: A Key Piece of the Puzzle

Mast cell activation syndrome (MCAS) is increasingly recognized as a significant contributor to persistent Long COVID symptoms, including brain fog. Here’s the connection:

COVID can destabilize mast cells, the immune cells that release histamine and other inflammatory mediators. Once activated, these mast cells can continue to degranulate inappropriately, creating a persistent inflammatory state. Histamine itself is a neurotransmitter that, in excess, disrupts cognitive function. The MCAS symptoms checklist can help you organize what you notice before an appointment.

Brain Fog, Fatigue and POTS: Overlapping Long COVID Symptoms

Post-COVID brain fog rarely travels alone. It commonly overlaps with post-exertional fatigue, unrefreshing sleep, headaches and dysautonomia, especially postural orthostatic tachycardia syndrome (POTS), in which the heart rate climbs sharply on standing and blood flow to the brain drops.

Treating the overlapping condition often lifts the fog as well. Raising fluid and salt intake, compression garments and medications used in POTS treatment can improve upright thinking, while the pacing strategies used for chronic fatigue syndrome (ME/CFS) help prevent the crashes that worsen cognition. If headaches are part of the picture, the page on COVID headache covers their patterns, and post-COVID fatigue gets its own detailed look.

How to Find a Clinician for Post-COVID Brain Fog

Start with your primary care physician and, where one is available, a hospital-based Long COVID clinic, since they can order the workup and coordinate referrals. Integrative and functional medicine practices that offer LDN, NAD+ infusions or hyperbaric oxygen are usually cash pay, so ask how they assess candidates, what they measure before and after treatment, and how they will decide whether it is working.

Regenerated.com lists clinics by treatment, including providers of hyperbaric oxygen therapy across the US. Listing order there is not paid ranking, Featured slots are labeled and capped, Verified means the clinic completed credential checks rather than paid for the badge, and the directory is free for patients. Inclusion in the directory is not an endorsement. The guide to Featured, Verified and organic listings explains each label.

Prognosis: Reasons for Optimism

Despite the frustration and uncertainty, the overall prognosis for post-COVID brain fog is encouraging. Most patients improve within 3 to 12 months, particularly when underlying drivers such as poor sleep, POTS or mast cell activation are identified and addressed. The brain has remarkable neuroplasticity, the ability to rewire and repair, and clinicians understand the condition far better than they did in 2020 and 2021.

What matters most is not waiting passively for it to resolve, but actively pursuing a diagnostic workup, implementing foundational interventions, and working with a clinician who understands the condition. Recovery is a process, not an event, and for most patients the trend is steady improvement.

Frequently Asked Questions

Is post-COVID brain fog permanent?

Post-COVID brain fog is not permanent for most people. Most improve meaningfully within 3 to 12 months, and gains can continue after that. A smaller group has symptoms beyond a year, and many of them respond to targeted treatment of drivers such as mast cell activation, poor sleep or POTS. In a large 2024 NEJM study, people whose symptoms had resolved scored similarly on cognitive tests to people who had short illnesses, although the long-term course for those still affected remains uncertain.

How long does brain fog last after COVID?

Brain fog after COVID typically lasts a few weeks to several months. Many people notice clear improvement between 3 and 6 months, a further group improves gradually through 6 to 12 months, and a minority still has symptoms after one to two years. Relapses during stress, illness or overexertion are common and usually temporary. Persistent cases often have a complicating factor, such as a sleep disorder or mast cell activation, that is worth investigating with a physician.

Can COVID brain fog come back after it resolves?

Yes, COVID brain fog can come back. Relapses are common during periods of physical or emotional stress, illness, poor sleep, or overexertion, and reinfection with SARS-CoV-2 can also retrigger cognitive symptoms. Most relapses are temporary and shorter than the first episode, especially once underlying contributing factors have been addressed. Pacing activity, protecting sleep and returning gradually to demanding mental work after a setback all help limit how long a relapse lasts.

Should I get a brain MRI for post-COVID brain fog?

A brain MRI is reasonable mainly to rule out other conditions, such as stroke, demyelination or a structural lesion. Expect a normal result: standard MRI is usually unremarkable in Long COVID brain fog. A normal scan does not mean nothing is wrong, because neuroinflammation, microglial activation and micro-clotting occur below what conventional MRI shows. Advanced imaging such as PET or dynamic contrast-enhanced MRI can show changes, but these are research tools and not routinely needed.

Does vaccination status affect post-COVID brain fog risk?

Vaccination before infection lowers, but does not eliminate, the risk of Long COVID, including brain fog. Several large studies report risk reductions ranging from 20 to 50%, depending on the population and variant. Vaccination after Long COVID has developed gives mixed results: some patients report improvement, while others see no change or a temporary worsening of symptoms. Discuss timing with your physician if you are still symptomatic.

What helps brain fog after COVID?

The most reliable help for brain fog after COVID comes from improving sleep, pacing physical and mental effort to avoid crashes, and treating contributing conditions such as POTS, sleep apnea or mast cell activation. Off-label options with early supportive data include low-dose naltrexone, H1 and H2 antihistamines and hyperbaric oxygen therapy, which improved cognition in one small sham-controlled trial. Computerized brain training and tDCS did not beat control activities in the RECOVER-NEURO trial.

Related Reading

Post-COVID brain fog is one cause covered in our full Brain Fog guide, which covers all causes of cognitive dysfunction, diagnostic approaches, and treatment strategies. If brain fog is affecting your life, whether from COVID, autoimmune conditions, or other causes, the pillar guide provides the complete framework for understanding and addressing it. For a treatment-focused companion, see Long COVID brain fog treatment options.